What it is
Regulatory status: cannabinoid product with legal and regulatory status varying by formulation and jurisdiction; not an FDA-approved sleep treatment
Mechanism evidence: human
CBN is a minor cannabinoid with activity at cannabinoid receptors, but human pharmacology and dose-response data remain limited.
What it is, why people use it, the evidence, and what to know before trying it.
Regulatory status: cannabinoid product with legal and regulatory status varying by formulation and jurisdiction; not an FDA-approved sleep treatment
Mechanism evidence: human
One small randomized trial reported fewer nighttime awakenings at a tested oral dose but did not establish faster sleep onset; the evidence base remains too thin for broad sleep claims.
Confidence: weak
Known side effects, interactions and use limits from reviewed sources.
Human safety data are limited. Drowsiness, impairment, interactions with alcohol or sedatives, product mislabeling, and THC contamination are practical concerns.
This review does not automatically apply to:
Public protocols that include CBN. Open one to see the full context and source.
Amount and timing patterns reported in public protocols; these are observations, not instructions. Private and hidden usage is excluded.
Continue into interventions that appear alongside this one.